Calamos Advisors’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-91,204
Closed -$4.42M 1227
2022
Q3
$4.42M Buy
91,204
+13,181
+17% +$639K 0.02% 709
2022
Q2
$3.07M Buy
+78,023
New +$3.07M 0.01% 795